Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 263

Similar articles for PubMed (Select 19336528)

1.

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

Maes W, Rosas GG, Verbinnen B, Boon L, De Vleeschouwer S, Ceuppens JL, Van Gool SW.

Neuro Oncol. 2009 Oct;11(5):529-42. doi: 10.1215/15228517-2009-004. Epub 2009 Mar 31.

2.

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.

Grauer OM, Sutmuller RP, van Maren W, Jacobs JF, Bennink E, Toonen LW, Nierkens S, Adema GJ.

Int J Cancer. 2008 Apr 15;122(8):1794-802.

PMID:
18076066
3.

Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.

Yamamoto M, Kamigaki T, Yamashita K, Hori Y, Hasegawa H, Kuroda D, Moriyama H, Nagata M, Ku Y, Kuroda Y.

Oncol Rep. 2009 Aug;22(2):337-43.

PMID:
19578774
4.

Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment.

Pellegatta S, Poliani PL, Stucchi E, Corno D, Colombo CA, Orzan F, Ravanini M, Finocchiaro G.

Neuro Oncol. 2010 Apr;12(4):377-88. doi: 10.1093/neuonc/nop024. Epub 2010 Jan 6.

5.

An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.

Zhu X, Lu C, Xiao B, Qiao J, Sun Y.

J Neurooncol. 2005 Aug;74(1):9-17.

PMID:
16078102
6.
7.

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.

Conroy H, Galvin KC, Higgins SC, Mills KH.

Cancer Immunol Immunother. 2012 Mar;61(3):425-31. doi: 10.1007/s00262-011-1188-y. Epub 2011 Dec 23.

PMID:
22193988
8.
9.

Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model.

Kim TG, Kim CH, Park JS, Park SD, Kim CK, Chung DS, Hong YK.

Clin Vaccine Immunol. 2010 Jan;17(1):143-53. doi: 10.1128/CVI.00292-09. Epub 2009 Nov 4.

10.

Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.

Yamanaka R, Honma J, Tsuchiya N, Yajima N, Kobayashi T, Tanaka R.

J Neurooncol. 2005 Apr;72(2):107-13.

PMID:
15925989
11.

Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.

Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, Caldera V, Nava S, Ravanini M, Facchetti F, Bruzzone MG, Finocchiaro G.

Cancer Res. 2006 Nov 1;66(21):10247-52.

12.

Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model.

Tan C, Reddy V, Dannull J, Ding E, Nair SK, Tyler DS, Pruitt SK, Lee WT.

J Transl Med. 2013 Jun 17;11:148. doi: 10.1186/1479-5876-11-148.

13.

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J.

Cancer Gene Ther. 2002 Sep;9(9):778-86.

14.

Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells.

Prasad SJ, Farrand KJ, Matthews SA, Chang JH, McHugh RS, Ronchese F.

J Immunol. 2005 Jan 1;174(1):90-8.

15.

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.

Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.

J Immunother. 2007 Nov-Dec;30(8):789-97.

PMID:
18049330
16.

CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma.

Johnson BD, Jing W, Orentas RJ.

J Immunother. 2007 Feb-Mar;30(2):203-14.

PMID:
17471167
17.

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.

Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4294-305.

18.

Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.

Xu M, Yao Y, Hua W, Wu Z, Zhong P, Mao Y, Zhou L, Luo F, Chu Y.

J Neurooncol. 2014 Feb;116(3):497-504. doi: 10.1007/s11060-013-1334-9. Epub 2014 Jan 8.

PMID:
24398615
19.

Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.

Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.

Gene Ther. 2004 Nov;11(21):1551-8.

PMID:
15343358
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk